Laboratory Medicine Program

Endometrial Carcinoma - NGS panel

Clinical Decription:
Multiple gene biomarker panel for endometrial cancer. Next generation sequencing is used to detect sequence variants, copy number changes and gene fusions with diagnostic, prognostic and/or therapeutic utility for this disease.

Method: Next-Generation Sequencing (NGS)

Component Tests Used: n/a

Reference Ranges Used:
Reference ranges for this test are not available online. However, they are included in all test results. For more information, please call us.

Specimen Type: Paraffin-embedded material (FFPE)/Cytology fluids
Volume: n/a

Shipping: room temperature or 4C

Special Instructions: Gene (KRAS, PIK3CA, POLE, PTEN) See requisitions for the full list of available testing and special instructions.

Testing Schedule(s): Please call

Turnaround Time: None

For more information, call 416.340.5227 or 1.866.865.5227